Journal of Clinical Endocrinology & Metabolism, Vol 62, 613-615, Copyright © 1986 by Endocrine Society

ARTICLES

Angiotensin II-like immunoreactivity in human ovarian follicular fluid

MD Culler, BC Tarlatzis, A Lightman, LA Fernandez, AH Decherney, A Negro-Vilar and F Naftolin

Human ovarian follicular fluid (hFF) has angiogenic activity, although the causative factors are unknown. We recently found that hFF contains renin activity which converts renin substrate to angiotensin I (AI). Since the enzymatic cleavage product of AI, angiotensin II (AII), is a potent stimulator of new vessel formation, we have examined Sephadex G- 25 column fractions of hFF and extracted hFF and plasma from individual patients for AII-like immunoreactivity (AII-IR). Eluent fractions from Sephadex G-25 column chromatography of hFF had significant AII-IR which eluted in the same fractions as synthetic AII. Individual, extracted FF samples contained approximately 10 times higher levels of AII-IR than extracts of plasma from the same patients. Serial dilutions of the Sephadex column fractions and extracted FF and plasma inhibited binding of 125I-AII to rabbit anti-AII serum in a manner parallel to the inhibition caused by synthetic AII, indicating that the detected immunoreactivity was not due to non-specific assay interference. In summary, the results indicate the presence of significant AII-like immunoreactivity in hFF. AII may now be considered as a potential mediator of the angiogenic activity present in hFF and may play an important paracrine and/or autocrine role in physiologic events in the ovary.

This article has been cited by other articles:

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				E. V. Bokal, H. M. Vrtovec, I. V. Klun, and I. Verdenik Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome Hum. Reprod., June 1, 2005; 20(6): 1562 - 1568. [Abstract] [Full Text] [PDF]

				H. Ando, T. Nagasaka, M. Nomura, S.-I. Tsukahara, Y. Kotani, S. Toda, Y. Murata, A. Itakura, and S. Mizutani Premenstrual Disappearance of Aminopeptidase A in Endometrial Stromal Cells around Endometrial Spiral Arteries/Arterioles during the Decidual Change J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2303 - 2309. [Abstract] [Full Text] [PDF]

				S. Toda, H. Ando, T. Nagasaka, S.-I. Tsukahara, M. Nomura, Y. Kotani, S. Nomura, F. Kikkawa, M. Tsujimoto, and S. Mizutani Existence of Placental Leucine Aminopeptidase/Oxytocinase/Insulin-Regulated Membrane Aminopeptidase in Human Endometrial Epithelial Cells J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1384 - 1389. [Abstract] [Full Text] [PDF]

				E. HASSAN, G. CREATSAS, G. MASTORAKOS, and S. MICHALAS Clinical Implications of the Ovarian/Endometrial Renin-Angiotensin-Aldosterone System Ann. N.Y. Acad. Sci., April 1, 2000; 900(1): 107 - 117. [Abstract] [Full Text] [PDF]

				E. Kotani, M. Sugimoto, H. Kamata, N. Fujii, M. Saitoh, S. Usuki, T. Kubo, K. Song, M. Miyazaki, K. Murakami, et al. Biological roles of angiotensin II via its type 2 receptor during rat follicle atresia Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E25 - E33. [Abstract] [Full Text] [PDF]

				Y. Gur, H. Breitbart, Y. Lax, S. Rubinstein, and N. Zamir Angiotensin II induces acrosomal exocytosis in bovine spermatozoa Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E87 - E93. [Abstract] [Full Text] [PDF]

				G. Nemeth, J. R. Pepperell, Y. Yamada, A. Palumbo, and F. Naftolin The Basis and Evidence of a Role for the Ovarian Renin-Angiotensin System in Health and Disease Reproductive Sciences, April 1, 1994; 1(2): 118 - 127. [Abstract] [PDF]

				A Pellicer, A Palumbo, A. DeCherney, and F Naftolin Blockage of ovulation by an angiotensin antagonist Science, June 17, 1988; 240(4859): 1660 - 1661. [Abstract] [PDF]